Xinhua News Agency, Beijing, February 21st - In the evening of February 21st, Sunnyou Medical released its 2024 annual earnings快报. During the reporting period, the company achieved a total operating revenue of 744 million yuan, a year-on-year decrease of 0.17%; net profit attributable to the parent company's owners was 103 million yuan, a year-on-year decrease of 54.44%; net profit attributable to the parent company's owners after deducting non-recurring gains and losses was 90.4665 million yuan, a year-on-year decrease of 55.66%.
Regarding the factors affecting performance, Sunnyou Medical stated that during the reporting period, in the face of opportunities and challenges, the company adhered to technological innovation, continuously improved management standards and operational capabilities, and maintained revenue basically flat compared to the previous year. Meanwhile, the company continued to attract high-end rehabilitation technology talents from various regions, significantly increasing the number of R&D personnel, leading to a rise in R&D staff compensation and related expenses. Additionally, as the company's construction projects were gradually put into use, depreciation and amortization increased compared to the previous year, resulting in a decline in net profit attributable to the parent company's owners and non-recurring profit and loss deductions.
Proofread by Mu Xiangtong